Driehaus Capital Management’s Precigen PGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-793,773
Closed -$3.07M 414
2026
Q1
$3.07M Sell
793,773
-2,807,901
-78% -$11.5M 0.02% 296
2025
Q4
$15.1M Buy
3,601,674
+1,559,164
+76% +$6.03M 0.1% 233
2025
Q3
$6.72M Buy
+2,042,510
New +$5.77M 0.05% 310
2015
Q2
Sell
-16,740
Closed -$726K 563
2015
Q1
$726K Sell
16,740
-5,861
-26% -$211K 0.03% 432
2014
Q4
$595K Buy
+22,601
New +$496K 0.02% 425

Other funds holding PGEN

Driehaus Capital Management's PGEN Position: Q2 2026 in Review

Driehaus Capital Management sold out of Precigen (PGEN) in Q2 2026, closing a stake of 793,773 shares — an estimated $3.07M sold.

Driehaus Capital Management first reported a position in PGEN in Q4 2014 and held it in 5 quarters. The position peaked at $15.1M in Q4 2025. 211 funds tracked by Wall St. Rank hold PGEN as of Q2 2026.

  • Driehaus Capital Management reported no remaining Precigen position as of Q2 2026 after selling out during the quarter.
  • Driehaus Capital Management sold 793,773 Precigen shares in Q2 2026, an estimated $3.07M.
  • Driehaus Capital Management first reported a position in Precigen in Q4 2014 and held it in 5 quarters.
  • Driehaus Capital Management's Precigen position peaked at $15.1M in Q4 2025.
  • 211 funds tracked by Wall St. Rank held Precigen as of Q2 2026.

Based on Driehaus Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.